EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33

Antonino Palumbo, Fabiola Atzeni, Giuseppe Murdaca iD, Sebastiano Gangemi

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241512143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Antonino Palumbo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, 98124 Messina, Italy. Hauptthemen laut MEDLINE: Cartilage, Articular, HMGB1 Protein, Osteoarthritis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a multifactorial disease in which genetics, aging, obesity, and trauma are well-known risk factors. It is the most prevalent joint disease and the largest disability problem worldwide. Recent findings have described the role of damage-associated molecular patterns (DAMPs) in the course of the disease. In particular, alarmins such as HMGB1, IL-33, and S100B, appear implicated in enhancing articular inflammation and favouring a catabolic switch in OA chondrocytes. The aims of this review are to clarify the molecular signalling of these three molecules in OA pathogenesis, to identify their possible use as staging biomarkers, and, most importantly, to find out whether they could be possible therapeutic targets. Osteoarthritic cartilage expresses increased levels of all three alarmins. HMGB1, in particular, is the most studied alarmin with increased levels in cartilage, synovium, and synovial fluid of OA patients. High levels of HMGB1 in synovial fluid of OA joints are positively correlated with radiological and clinical severity. Counteracting HMGB1 strategies have revealed improving results in articular cells from OA patients and in OA animal models. Therefore, drugs against this alarmin, such as anti-HMGB1 antibodies, could be new treatment possibilities that can modify the disease course since available medications only alleviate symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cartilage, ArticularHMGB1 ProteinOsteoarthritisAnimalsAlarminsChondrocytesInterleukin-33JointsSynovial MembraneS100 Calcium Binding Protein beta Subunit

Stichwörter der Autor:innen

DAMPsHMGB1IL-33S100Balarminscytokinesosteoarthritis

Substanzen

AlarminsHMGB1 ProteinInterleukin-33HMGB1 protein, humanS100B protein, humanS100 Calcium Binding Protein beta SubunitIL33 protein, human

Autor:innen und Institutionen

  • Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, 98124 Messina, Italy.
  • Department of Internal Medicine, University of Genova, 16132 Genova, Italy.
  • IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
  • School and Operative Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

ORCID-Profile: Giuseppe Murdaca

Zitieren

APA

Palumbo, A., Atzeni, F., Murdaca, G., & Gangemi, S. (2023). The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512143

Vancouver

Palumbo A, Atzeni F, Murdaca G, Gangemi S. The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512143

BibTeX
@article{Palumbo2023,
  author = {Palumbo, Antonino and Atzeni, Fabiola and Murdaca, Giuseppe and Gangemi, Sebastiano},
  title = {The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241512143}
}
Kostenlos starten →